Clarification10 April 2026 at 04:41 am
Krebs Biochemicals clarifies on significant price movement
AI Summary
Krebs Biochemicals & Industries Ltd responded to an email from the BSE regarding significant movement in its security price. The company clarified that there is no material information or event requiring disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that, in its opinion, has a bearing on the stock's price movement. The company further stated that it regularly disseminates relevant information and details in compliance with SEBI regulations.
Key Highlights
- Company responded to BSE query on stock price movement.
- No undisclosed material information affecting stock price.
- Company asserts compliance with SEBI disclosure norms.